VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 560 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2015. The put-call ratio across all filers is 2.18 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,065,000 | +18.1% | 45,839 | +5.5% | 0.07% | -13.1% |
| Q4 2017 | $902,000 | +691.2% | 43,455 | +449.2% | 0.08% | +546.2% |
| Q4 2016 | $114,000 | -94.5% | 7,912 | -90.0% | 0.01% | -96.1% |
| Q1 2016 | $2,070,000 | -30.0% | 78,727 | +374.7% | 0.33% | -35.9% |
| Q3 2015 | $2,958,000 | +260.3% | 16,583 | +301.0% | 0.52% | +154.2% |
| Q1 2015 | $821,000 | +16.6% | 4,135 | -31.1% | 0.20% | -41.0% |
| Q4 2013 | $704,000 | +7.2% | 6,000 | -4.8% | 0.34% | -15.5% |
| Q3 2013 | $657,000 | – | 6,300 | – | 0.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,586,582 | $864,160,000 | 32.02% |
| FARLEY CAPITAL L.P. | 341,518 | $44,807,000 | 30.12% |
| LeVasseur Capital Partners LLC | 190,404 | $24,981,000 | 29.94% |
| Ruane, Cunniff & Goldfarb | 34,494,015 | $4,525,615,000 | 23.97% |
| ValueAct Holdings | 18,923,877 | $2,482,813,000 | 16.64% |
| White River Investment Partners, LLC | 90,099 | $11,820,000 | 16.35% |
| Tesuji Partners | 1,368,040 | $179,487,000 | 15.45% |
| Arrow Capital Management, LLC | 197,500 | $25,912,000 | 15.11% |
| Hound Partners | 3,576,998 | $469,302,000 | 14.87% |
| Brahman Capital Corp. | 4,457,153 | $584,778,000 | 12.82% |